Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Products>This Product


Product Description

"The compact Minichiller® reduces water consumption to zero, offering a low cost, chilled water supply with environmentally friendly refrigeration for a variety of laboratory applications.
With the ever rising cost and environmental impact of waste water, Scientists and Facility Managers are increasingly looking for alternative ways of cooling applications in the laboratory. A calculation, based on water  consumption, shows that in a working week (8-hours a day, 5 days a week), the Minichiller® saves approximately 48,000 litres of water, and as the Minichiller® is low in cost, it offers a fast return on investment which can be measured in months.
The compact Minichiller® is designed as a space saving tower and with a footprint of just 225 x 360mm the Huber Minichiller® takes up less bench space than many laptops. With a temperature range of -20 to +40°C and cooling capacity of 300 watts at 15°C, Minichillers® are ideal for cooling reaction blocks, vapour traps, vacuum pump condensers, rotary evaporators or heat exchangers, supplying predictable and correct pressure, flow and temperature to applications resulting in tangible process efficiencies. Because the Minichiller's® internal volume is only 2 litres, it eliminates the risk of flooding in the laboratory. This allows the process to be run unattended further increasing efficiency.
The Minichiller® features an easy to use Microprocessor control with a large temperature display. Alternatively for applications requiring more functionality the controller can be supplied as an ""Advanced"" version which includes an RS232 interface and an external Pt100 sensor connection. The Minichiller® is also available with 1kW heating power and extended temperature range from -20°C to 100°C.
Minichillers® are available as both water and air-cooled units and with standard or advanced functionality. All units are CFC and H-CFC free and use natural refrigerants."

Product Minichiller®
Company Huber Product Directory
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Huber Product Directory
Peter Huber Kältemaschinenbau GmbH Werner-von-Siemens-Strasse 1 D-77656 Offenburg

Tel: +49-781-96030
Fax: +49-781-57211

Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos